HIQPHARM
Index Performance
+6.04%
HIQPHARM
+11.40%
TMLARGE
+9.87%
SPY
+5.24%
DIA
This index is hidden.
Visit your dashboard to unhide.
Overview
Description
Pharma
- TickerHIQPHARM
- Inception Date12/04/2023
- WeightingSq. Root Market Cap
- # of holdings127
What's inside?
Holdings
All holdings as of July 23, 2024
CSV download
| Eli Lilly & Co. (LLY) | 5.20% | $780.46B | 25.98% | 80.91% | 20.23 |
| Novo Nordisk A/S (NOVO.B) | 3.85% | $430.66B | 22.45% | 84.83% | 16.20 |
| Johnson & Johnson (JNJ) | 3.29% | $384.20B | -12.12% | 68.99% | 4.27 |
| Merck & Co., Inc. (MRK) | 3.12% | $318.75B | 8.38% | 75.11% | 5.96 |
| Roche Holding AG (RO) | 3.10% | $254.69B | -7.21% | 73.06% | 3.99 |
| AstraZeneca PLC (AZN) | 3.04% | $240.55B | 12.44% | 75.69% | 5.48 |
| AbbVie, Inc. (ABBV) | 3.01% | $321.69B | 4.31% | 84.95% | N/A |
| Novartis AG (NOVN) | 2.73% | $217.28B | -7.58% | 74.29% | 5.10 |
| Amgen, Inc. (AMGN) | 2.55% | $179.33B | 22.19% | 56.73% | 7.04 |
| Pfizer Inc. (PFE) | 2.43% | $171.02B | -18.61% | 70.56% | 3.92 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 2.09% | $127.03B | 14.21% | 87.25% | 9.80 |
| Sanofi (SAN) | 2.07% | $133.33B | 0.17% | 61.52% | 2.85 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.92% | $115.32B | -0.54% | 82.58% | 7.86 |
| Daiichi Sankyo Co., Ltd. (4568) | 1.59% | $71.98B | 25.28% | 73.78% | 5.27 |
| McKesson Corp. (MCK) | 1.56% | $77.27B | 11.65% | 3.95% | 0.24 |
| Zoetis, Inc. (ZTS) | 1.53% | $82.48B | 9.50% | 68.95% | 9.44 |
| GSK Plc (GSK) | 1.51% | $79.94B | 5.93% | 73.69% | 2.71 |
| Bristol Myers Squibb Co. (BMY) | 1.49% | $91.77B | 4.66% | 55.54% | 3.46 |
| CVS Health Corp. (CVS) | 1.31% | $73.63B | 3.60% | 14.22% | 0.47 |
| Chugai Pharmaceutical Co., Ltd. (4519) | 1.31% | $64.19B | 18.13% | 72.16% | N/A |
| Lonza Group AG (LONN) | 1.21% | $45.64B | 7.94% | 27.04% | 4.11 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 1.17% | $30.09B | 54.82% | 86.65% | 9.57 |
| Haleon Plc (HLN) | 1.15% | $40.93B | 4.09% | 61.13% | 3.39 |
| Takeda Pharmaceutical Co., Ltd. (4502) | 1.12% | $43.43B | 5.87% | 54.53% | 2.72 |
| Cencora, Inc. (COR) | 1.12% | $45.30B | 7.81% | 3.30% | 0.19 |
| UCB SA (UCB) | 1.10% | $30.87B | -4.80% | 63.63% | 3.33 |
| Biogen, Inc. (BIIB) | 0.99% | $33.11B | -5.62% | 68.65% | 4.02 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) | 0.98% | $36.33B | 9.15% | 84.13% | 11.74 |
| Otsuka Holdings Co., Ltd. (4578) | 0.96% | $26.03B | 15.87% | 70.78% | 1.56 |
| Bayer AG (BAYN) | 0.91% | $29.35B | -4.34% | 60.31% | 1.48 |
| Novozymes A/S (NZYM.B) | 0.88% | $17.32B | 1.97% | 52.03% | 6.15 |
| United Therapeutics Corp. (UTHR) | 0.83% | $14.92B | 33.70% | 89.24% | 3.73 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 0.83% | $19.04B | 4.84% | 46.56% | 2.06 |
| Merck KGaA (MRK) | 0.79% | $21.78B | -3.27% | 58.77% | 3.79 |
| Sandoz Group AG (SDZ) | 0.78% | $13.67B | 0.74% | N/A | N/A |
| Cardinal Health, Inc. (CAH) | 0.77% | $23.60B | 8.76% | 3.43% | 0.13 |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) | 0.74% | $17.22B | 3.60% | N/A | N/A |
| Astellas Pharma, Inc. (4503) | 0.73% | $19.41B | 5.60% | 75.60% | 2.26 |
| Sarepta Therapeutics, Inc. (SRPT) | 0.71% | $13.95B | 63.10% | 85.66% | 9.14 |
| BeiGene Ltd. (688235) | 0.69% | $17.46B | 76.35% | 80.17% | 8.40 |
| Incyte Corp. (INCY) | 0.69% | $15.42B | 8.93% | 91.24% | 2.42 |
| Neurocrine Biosciences, Inc. (NBIX) | 0.68% | $14.70B | 22.57% | 97.52% | 6.87 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 0.67% | $16.25B | 9.61% | 78.54% | 7.05 |
| Hansoh Pharmaceutical Group Co., Ltd. (3692) | 0.65% | $12.52B | 2.33% | 89.80% | 6.47 |
| Viatris, Inc. (VTRS) | 0.63% | $14.00B | -1.70% | 41.57% | 2.06 |
| Yunnan Baiyao Group Co., Ltd. (000538) | 0.62% | $11.94B | 2.43% | 29.62% | 1.98 |
| Royalty Pharma Plc (RPRX) | 0.61% | $12.97B | -16.96% | N/A | 11.96 |
| Eisai Co., Ltd. (4523) | 0.61% | $12.26B | -0.36% | 76.01% | 2.30 |
| Avantor, Inc. (AVTR) | 0.60% | $15.50B | -5.65% | 33.96% | 3.28 |
| Recordati SpA (REC) | 0.59% | $11.70B | 10.24% | 68.37% | 5.68 |
| Shionogi & Co., Ltd. (4507) | 0.58% | $12.44B | 1.97% | 84.83% | 4.41 |
| Sartorius Stedim Biotech SA (DIM) | 0.57% | $17.35B | 4.54% | 43.36% | 6.34 |
| Catalent, Inc. (CTLT) | 0.57% | $10.58B | 3.57% | 21.32% | 3.64 |
| Ipsen SA (IPN) | 0.56% | $9.10B | 3.39% | 75.10% | 2.86 |
| Sartorius AG (SRT) | 0.56% | $15.52B | 3.45% | 45.11% | 5.24 |
| CSPC Pharmaceutical Group Ltd. (1093) | 0.53% | $8.86B | -3.40% | 70.51% | 2.15 |
| WuXi AppTec Co., Ltd. (603259) | 0.53% | $15.15B | 2.27% | 39.99% | 5.18 |
| Intra-Cellular Therapies, Inc. (ITCI) | 0.52% | $8.53B | 52.00% | 93.17% | 12.15 |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) | 0.48% | $7.45B | 14.83% | 52.94% | 2.01 |
| Innovent Biologics, Inc. (1801) | 0.48% | $8.06B | 29.43% | 81.69% | 8.54 |
| SciClone Pharmaceuticals (Holdings) Ltd. (6600) | 0.48% | $1.45B | 9.05% | 74.46% | 1.90 |
| Grifols SA (GRF) | 0.47% | $6.18B | 8.71% | 35.24% | 3.37 |
| Ascendis Pharma A/S (ASND) | 0.46% | $7.75B | 188.79% | 88.27% | 25.21 |
| Orion Oyj (ORNBV) | 0.46% | $6.29B | 10.25% | 55.33% | 3.98 |
| Organon & Co. (OGN) | 0.45% | $5.68B | 5.46% | 59.00% | 2.05 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) | 0.44% | $7.70B | -6.84% | 49.55% | 2.31 |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (600332) | 0.44% | $6.41B | 6.12% | 21.79% | 0.61 |
| Beijing Tong RenTang Co., Ltd. (600085) | 0.43% | $6.93B | 2.49% | 42.48% | 3.13 |
| Jazz Pharmaceuticals Plc (JAZZ) | 0.43% | $6.91B | 1.03% | 72.15% | 2.99 |
| Ono Pharmaceutical Co., Ltd. (4528) | 0.43% | $6.83B | 12.41% | 74.14% | 1.97 |
| Huadong Medicine Co., Ltd. (000963) | 0.43% | $6.94B | 2.91% | 31.66% | 1.34 |
| Sino Biopharmaceutical Ltd. (1177) | 0.43% | $6.62B | -13.50% | 80.95% | 2.52 |
| H. Lundbeck A/S (HLUN.B) | 0.42% | $4.74B | 5.02% | 80.06% | 1.59 |
| Walgreens Boots Alliance, Inc. (WBA) | 0.42% | $9.94B | 2.64% | 16.10% | 0.34 |
| Sichuan Kelun Pharmaceutical Co., Ltd. (002422) | 0.41% | $5.53B | 11.15% | 55.38% | 2.27 |
| Twist Bioscience Corp. (TWST) | 0.40% | $3.35B | 25.13% | 41.01% | 6.41 |
| Hangzhou Tigermed Consulting Co., Ltd. (300347) | 0.38% | $4.53B | -8.08% | 37.54% | 6.38 |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223) | 0.38% | $4.69B | -17.40% | 49.43% | 3.80 |
| PT Kalbe Farma Tbk (KLBF) | 0.37% | $4.58B | 6.28% | 38.49% | 2.15 |
| Axsome Therapeutics, Inc. (AXSM) | 0.37% | $4.08B | -20.70% | 89.16% | 14.50 |
| BridgeBio Pharma, Inc. (BBIO) | 0.36% | $5.00B | 11,461.88% | 99.10% | 30.87 |
| Morphic Holding, Inc. (MORF) | 0.36% | $2.84B | N/A | N/A | N/A |
| SK Biopharmaceuticals Co., Ltd. (326030) | 0.36% | $4.76B | 87.51% | 86.72% | 17.47 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) | 0.36% | $4.33B | 23.01% | 71.07% | 8.58 |
| Dong-E-E-Jiao Co., Ltd. (000423) | 0.35% | $4.26B | 36.36% | 71.41% | 6.12 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) | 0.34% | $3.27B | 21.45% | 59.26% | 2.84 |
| Livzon Pharmaceutical Group, Inc. (000513) | 0.34% | $4.03B | -4.80% | 64.32% | 2.32 |
| CSPC Innovation Pharmaceutical Co., Ltd. (300765) | 0.33% | $4.24B | -23.78% | 45.79% | 18.04 |
| Changchun High-Tech Industry (Group) Co., Ltd. (000661) | 0.33% | $5.07B | 14.51% | 83.30% | 3.06 |
| Pharmaron Beijing Co., Ltd. (300759) | 0.32% | $4.46B | -2.43% | 31.90% | 3.52 |
| Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) | 0.32% | $3.94B | 0.49% | 80.81% | 2.48 |
| China National Medicines Co., Ltd. (600511) | 0.32% | $3.33B | 7.96% | 6.82% | 0.40 |
| Prestige Consumer Healthcare, Inc. (PBH) | 0.32% | $3.50B | -0.21% | 53.48% | 4.21 |
| Humanwell Healthcare (Group) Co., Ltd. (600079) | 0.31% | $4.06B | 2.27% | 45.97% | 1.64 |
| Shanghai Junshi Biosciences Co., Ltd. (688180) | 0.31% | $3.39B | 49.13% | 71.19% | 15.80 |
| Redcare Pharmacy NV (SAE) | 0.31% | $2.93B | 50.57% | 20.45% | 1.56 |
| Hualan Biological Engineering, Inc. (002007) | 0.30% | $3.55B | -10.41% | 55.20% | 6.85 |
| PTC Therapeutics, Inc. (PTCT) | 0.29% | $2.57B | -4.66% | 68.46% | 1.90 |
| Wuxi Biologics (Cayman), Inc. (2269) | 0.29% | $5.67B | 6.01% | 40.08% | 6.66 |
| Sinopharm Group Co., Ltd. (1099) | 0.28% | $3.15B | 2.67% | 7.83% | 0.23 |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) | 0.27% | $3.51B | -36.27% | 50.61% | 3.94 |
| Hypera SA (HYPE3) | 0.27% | $3.12B | 7.56% | 58.74% | 3.56 |
| Jointown Pharmaceutical Group Co., Ltd. (600998) | 0.27% | $3.14B | -3.86% | 6.96% | 0.43 |
| ACADIA Pharmaceuticals, Inc. (ACAD) | 0.26% | $3.06B | 73.75% | 88.85% | 3.28 |
| Apeloa Pharmaceutical Co., Ltd. (000739) | 0.26% | $2.25B | 3.83% | 23.85% | 1.24 |
| Amicus Therapeutics, Inc. (FOLD) | 0.26% | $3.04B | 27.97% | 85.76% | 8.91 |
| 3SBio, Inc. (1530) | 0.26% | $1.92B | 8.27% | 84.98% | 2.27 |
| Bausch Health Cos., Inc. (BHC) | 0.26% | $2.16B | 10.75% | 57.55% | 2.92 |
| Joincare Pharmaceutical Group Industry Co., Ltd. (600380) | 0.26% | $2.61B | -4.69% | 63.00% | 1.31 |
| Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. (603707) | 0.25% | $2.59B | -22.68% | 38.25% | 5.21 |
| Springworks Therapeutics, Inc. (SWTX) | 0.25% | $2.73B | N/A | 90.81% | 121.00 |
| Patterson Cos., Inc. (PDCO) | 0.25% | $2.28B | 1.50% | 21.01% | 0.47 |
| Asymchem Laboratories (Tianjin) Co., Ltd. (002821) | 0.25% | $3.34B | -39.35% | 41.82% | 3.35 |
| China Meheco Group Co., Ltd. (600056) | 0.23% | $2.09B | -29.98% | 10.06% | 0.67 |
| Shandong Buchang Pharmaceuticals Co., Ltd. (603858) | 0.23% | $2.19B | -24.81% | 58.02% | 1.71 |
| China Traditional Chinese Medicine Holdings Co. Ltd. (570) | 0.23% | $2.18B | 20.38% | 51.18% | 1.20 |
| BioArctic AB (BRCTF) | 0.23% | $1.51B | -92.47% | 92.46% | 73.50 |
| Zai Lab Ltd. (9688) | 0.23% | $1.84B | 38.46% | 61.42% | 3.15 |
| Fortrea Holdings, Inc. (FTRE) | 0.22% | $2.34B | -13.36% | 12.99% | 1.72 |
| Tonghua Dongbao Pharmaceutical Co., Ltd. (600867) | 0.22% | $2.07B | -11.15% | 78.55% | 6.47 |
| Galapagos NV (GLPG) | 0.20% | $1.80B | -65.10% | 95.92% | -6.68 |
| Chongqing Taiji Industry (Group) Co., Ltd. (600129) | 0.20% | $2.00B | -4.87% | 45.93% | 1.43 |
| Arvinas, Inc. (ARVN) | 0.20% | $2.02B | -22.15% | 93.28% | 25.07 |
| Luye Pharma Group Ltd. (2186) | 0.20% | $1.30B | -2.41% | 68.31% | 2.43 |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (603456) | 0.18% | $1.65B | -16.32% | 33.12% | 2.70 |
| Simulations Plus, Inc. (SLP) | 0.15% | $790.11M | 14.23% | 71.49% | 12.95 |
| MediPharm Labs Corp. (LABS) | 0.03% | $20.48M | 67.23% | 27.62% | 0.47 |
Market data by FactSet